It is very uncertain whether coasting changes clinical Pregnancy compared with early unilateral follicular aspiration (very low certainty).
The review found no eligible studies for this question.
Bisphosphonates probably leads to lower bone metastases compared with placebo/observation (moderate certainty).
Bisphosphonates leads to lower overall survival compared with placebo/observation (high certainty).
Bisphosphonates leads to lower overall survival postmenopausal women compared with placebo/observation (high certainty).
Bisphosphonates showed no clear difference in overall survival: pre‐ or perimenopausal women compared with placebo/observation (high certainty).
Bisphosphonates showed no clear difference in disease‐free progression compared with placebo/observation (high certainty).
Bisphosphonates leads to lower disease‐free progression: postmenopausal women compared with placebo/observation (high certainty).
Bisphosphonates showed no clear difference in disease‐free progression: pre‐ or perimenopausal women compared with placebo/observation (high certainty).
Bisphosphonates showed no clear difference in fracture incidence compared with placebo/observation (moderate certainty).
Chemotherapy alone may leads to lower secondary malignant neoplasms compared with same chemotherapy plus radiotherapy (low certainty).
Fewer showed no clear difference in secondary malignant neoplasms compared with more courses of chemotherapy (with or without radiotherapy (moderate certainty).
Fewer showed no clear difference in death compared with more courses of chemotherapy (with or without radiotherapy (high certainty).
Fewer showed no clear difference in progression/relapse compared with more courses of chemotherapy (with or without radiotherapy (high certainty).
Chemotherapy alone showed no clear difference in death compared with same chemotherapy plus radiotherapy (moderate certainty).
Chemotherapy alone showed no clear difference in progression/relapse compared with same chemotherapy plus radiotherapy (moderate certainty).
Chemotherapy plus involved‐field radiation showed no clear difference in secondary malignant neoplasms compared with same chemotherapy plus extended‐field radiation (low certainty).
Chemotherapy plus involved‐field radiation showed no clear difference in death compared with same chemotherapy plus extended‐field radiation (high certainty).